Note:
The product is for research use only, not for use in diagnostic or therapeutic procedures
|
Product Name |
LILRA2/3 Antibody |
Synonyms |
LILRA2; ILT1; LIR7; Leukocyte immunoglobulin-like receptor subfamily A member 2; CD85 antigen-like family member H; Immunoglobulin-like transcript 1; ILT-1; Leukocyte immunoglobulin-like receptor 7; LIR-7; CD85h; LILRA3; ILT6; LIR4; Leukocyte immunoglobulin-like receptor subfamily A member 3; CD85 antigen-like family member E; Immunoglobulin-like transcript 6; ILT-6; Leukocyte immunoglobulin-like receptor 4; LIR-4; Monocyte inhibitory receptor HM43/HM31; CD85e |
Immunogen |
The antiserum was produced against synthesized peptide derived from the Internal region of human LILRA2/3. |
Immunogen Range |
121-170 |
Clonality |
Polyclonal
|
Application Dilutions |
WB: 1:500~1:1000 ELISA: 1:10000 |
Specificity |
LILRA2/3 Antibody detects endogenous levels of LILRA2/3 protein. |
Purification |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using peptide. |
Physical Form |
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Storage/Stability |
Stable at -20°C for at least 1 year. |
NCBI Gene Symbol |
LILRA2/LILRA3 |
Database Links |
Gene ID: 11027/11026 Swiss-Prot #: Q8N149/Q8N6C8
|
Target Modification |
Unmodified/Total |
Modification Sites |
|
Application Images
|
Image 1 |
Western blot analysis of lysate from MCF7 cells, using LILRA2/3 Antibody. |